Optimistic family communication about major complications of type I diabetes improves disease outcomes — even in families with limited knowledge about the risks, a study finds.
Toe touching accurately predicts foot-ulcer risk
Lightly touching the toes of a patient with diabetes is an effective way to assess the risk of foot ulcers, research shows. A UK study noted that in the absence of neurologic devices such as monofilament, many doctors “touch the feet with cotton wool or even their fingers”. The team from Ipswich Hospital in Norfolk [...]
Body weight is proven to influence insulin resistance
Women cutting down on insulin to lose weight
ROADMAP – fact and fallacy in one paper
Liver disease neglected in diabetes
More collaboration needed in diabetes care
Better BP control with nurse-led interventions
Nurse-led interventions achieve better blood pressure control in patients with diabetes than usual care, a meta-analysis has concluded. The analysis identified 11 relevant studies. Interventions included rigorous use of a treatment algorithm, nurse prescribing, community monitoring and nurse-led clinics. Overall, the use of any nurse-led intervention resulted in a 5.8mmHg improvement in systolic blood pressure [...]
Pancreatic malignancy may present as diabetes
Type II diabetes can be a sign of underlying pancreatic malignancy, according to Australian experts. In a letter to the editor of the Australian and New Zealand Journal of Surgery, the authors from John Hunter Hospital in Newcastle detailed the case history of an atypical presentation of malignant melanoma in the form of new-onset type [...]
Study finds paricalcitol a promising prospect in diabetic albuminuria
Paricalcitol, a calcitriol-analogue vitamin D receptor activator, can safely lower residual albuminuria in patients with type 2 diabetes, a randomised trial has shown. The international VITAL study randomised 281 patients with albuminuria to 24 weeks’ treatment with paricalcitol 1mcg/day or 2mcg/day or placebo in addition to pre-existing ACE inhibitor or angiotensin receptor-blocker therapy. The 2mcg [...]